On behalf of all coauthors, as principal investigator, I write to request retraction of the article, “Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries,”1 published online on August 23, 2018, and in the November 2018 issue of JAMA Oncology.
This article reports the results of a population-based cohort study that included 48 414 participants with gastroesophageal reflux disease (GERD) who underwent antireflux surgery and 894 492 participants with GERD treated with medication only in Denmark, Finland, Iceland, Norway, and Sweden. We concluded that the risk of esophageal adenocarcinoma decreased over time after antireflux surgery to reach a similar level as that in the background population and was similar when comparing individuals who underwent surgery with those who did not.
Lagergren J. Notice of Retraction. Maret-Ouda et al. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol. 2018;4(11):1576-1582. JAMA Oncol. 2019;5(5):744–745. doi:10.1001/jamaoncol.2019.0653
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: